Pembrolizumab in Patients with Tumors with High Tumor Mutational Burden: Results from the Targeted Agent and Profiling Utilization Registry Study

Herbert L. Duvivier, Michael Rothe, Pam K. Mangat, Elizabeth Garrett-Mayer, Eugene R. Ahn, Tareq Al Baghdadi, Ajjai S. Alva, Stephanie A. Dublis, Timothy L. Cannon, Carmen J. Calfa, Rui Li, Deepti Behl, Vi K. Chiu, Philip J. Gold, Alissa S. Marr, Kathryn F. Mileham, Steven Francis Powell, Jordi Rodon, Ramya Thota, Gina N. GranthamAbigail Gregory, Dominique C. Hinshaw, Susan Halabi, Richard L. SchilskyShow 4 othersShow less